Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.8050 (0.92%) ($42.8050 - $42.8050) on Thu. Mar. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.98% (three month average) | RSI | 21 | Latest Price | $42.8050(0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.4% a day on average for past five trading days. | Weekly Trend | HALO declines -6.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(43%) XBI(43%) IFRA(40%) IWO(37%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -0.99% in a week (0% probabilities). VXX(-16%) VIXM(-13%) UUP(-12%) GLD(-10%) BND(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.99% (StdDev 1.98%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $35.32(-17.49%) | Resistance Level | $47.62 | 5 Day Moving Average | $44.08(-2.89%) | 10 Day Moving Average | $45.87(-6.68%) | 20 Day Moving Average | $47.62(-10.11%) | To recent high | -27.4% | To recent low | 0.9% | Market Cap | $5.85b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |